In today's health matters, a Food and Drug Administration advisory panel meeting is underway analyzing silicone breast implant safety studies.
The goal the agency set up for its general and plastic surgery devices panel is to find better ways to assess the overall performance of silicone implants.
Silicone breast implants were banned for 14 years because of concerns about possible links to several diseases. They were approved for use in women over 22 in 2006.
One of the reasons the FDA lifted its ban was it noted there was not a lot of data on adverse effects. The FDA plans to update the panel on current studies and ask for recommendations on how to make these studies more effective.
The panel will also be asked for recommendations on ways to track and study future breast implants after they are approved.